ABBOTT RES BV has a total of 52 patent applications. Its first patent ever was published in 2004. It filed its patents most often in Australia, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and computer technology are NVIP PTY LTD, BALIOPHARM AG and ELUSYS THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 8 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Japan | 3 | |
#4 | Singapore | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | Chile | 2 | |
#8 | China | 2 | |
#9 | Colombia | 2 | |
#10 | Costa Rica | 2 | |
#11 | Dominican Republic | 2 | |
#12 | Hong Kong | 2 | |
#13 | Republic of Korea | 2 | |
#14 | Mexico | 2 | |
#15 | New Zealand | 2 | |
#16 | Peru | 2 | |
#17 | Taiwan | 2 | |
#18 | Argentina | 1 | |
#19 | Ecuador | 1 | |
#20 | Israel | 1 | |
#21 | Russian Federation | 1 | |
#22 | United States | 1 | |
#23 | Uruguay | 1 | |
#24 | WIPO (World Intellectual Property Organization) | 1 | |
#25 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Computer technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Stine William B | 21 |
#2 | Siedler Michael | 20 |
#3 | Kumar Vineet | 20 |
#4 | Weber Carsten | 20 |
#5 | Chari Ravi | 20 |
#6 | Fraunhofer Wolfgang | 19 |
#7 | Saedler Rainer | 18 |
#8 | Powell John | 17 |
#9 | Liu Wei | 16 |
#10 | Maginn Mark | 16 |
Publication | Filing date | Title |
---|---|---|
US2017260264A1 | Antibodies against nerve growth factor (ngf) with enhanced in vivo stability | |
AU2014277649A1 | Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect | |
AU2012201465A1 | Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect | |
AU2011227335A1 | Anti-nerve growth factor (NGF) antibody compositions | |
EP2448970A1 | Antibodies against nerve growth factor (ngf) with enhanced in vivo stability |